|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01255 TATA HEALTH
Nominal 
0.300 0.000 (0.000%) | 2024/12 - Final HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | -- | 13,005 | (4,896) | 255 |
| Net Cash from / (used in) Investing Activities | -- | -- | 7,928 | (39,814) | (18,964) |
| Net Cash from / (used in) Financing Activities | -- | -- | (13,965) | 43,241 | 12 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | -- | 6,968 | (1,469) | (18,697) |
| Cash & Cash Equivalents at beginning of period | -- | -- | 26,743 | 28,208 | 46,820 |
| Effect of Foreign Exchange Rate Changes | -- | -- | (62) | 4 | 85 |
| Others | -- | -- | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | -- | 33,649 | 26,743 | 28,208 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 20,596 |
| %Change | -- |
| EPS / (LPS) | HKD 0.080 |
| NBV Per Share ($) | HKD -0.201 |